Literature DB >> 18689713

Subclinical mastitis is common among Ghanaian women lactating 3 to 4 months postpartum.

Richmond N O Aryeetey1, Grace S Marquis, Leo Timms, Anna Lartey, Lucy Brakohiapa.   

Abstract

Subclinical mastitis (SCM) is an asymptomatic inflammation of mammary tissue and has been associated with lactation failure, suboptimal growth in early infancy, and increased risk of mother-to-child transmission of HIV via breast milk. A rapid survey was carried out to determine the prevalence of SCM among lactating Ghanaian women between 3 and 4 months postpartum. Bilateral breast milk samples were obtained from 117 lactating women in Manya Krobo, Ghana and analyzed for sodium (Na) and potassium (K). An elevated sodium/potassium ratio (Na/K) above 1.0 was considered indicative of SCM. Overall, SCM prevalence was observed among 45.3% of the women. About 30% of the women had unilateral SCM. Na/K was associated with maternal age. The high SCM prevalence in Manya Krobo suggests the need for lactation support to reduce SCM and the risk of poor infant outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18689713     DOI: 10.1177/0890334408316077

Source DB:  PubMed          Journal:  J Hum Lact        ISSN: 0890-3344            Impact factor:   2.219


  13 in total

Review 1.  Mastitis therapy and antimicrobial susceptibility: a multispecies review with a focus on antibiotic treatment of mastitis in dairy cattle.

Authors:  John Barlow
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-09       Impact factor: 2.673

2.  Vitamin supplementation increases risk of subclinical mastitis in HIV-infected women.

Authors:  Joanne E Arsenault; Said Aboud; Karim P Manji; Wafaie W Fawzi; Eduardo Villamor
Journal:  J Nutr       Date:  2010-08-25       Impact factor: 4.798

3.  Subclinical mastitis occurs frequently in association with dramatic changes in inflammatory/anti-inflammatory breast milk components.

Authors:  Edouard Tuaillon; Johanes Viljoen; Pierre Dujols; Gilles Cambonie; Pierre-Alain Rubbo; Nicolas Nagot; Ruth M Bland; Stéphanie Badiou; Marie-Louise Newell; Philippe Van de Perre
Journal:  Pediatr Res       Date:  2016-11-04       Impact factor: 3.756

4.  Maternal accounts of their breast-feeding intent and early challenges after caesarean childbirth.

Authors:  Kristin P Tully; Helen L Ball
Journal:  Midwifery       Date:  2013-10-26       Impact factor: 2.372

Review 5.  Inflammatory mediators in mastitis and lactation insufficiency.

Authors:  Wendy V Ingman; Danielle J Glynn; Mark R Hutchinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-06-25       Impact factor: 2.673

6.  HIV-negative status is associated with very early onset of lactation among Ghanaian women.

Authors:  Gloria E Otoo; Grace S Marquis; Daniel W Sellen; Donna J Chapman; Rafael Pérez-Escamilla
Journal:  J Hum Lact       Date:  2009-10-06       Impact factor: 2.219

7.  Subclinical mastitis may not reduce breastmilk intake during established lactation.

Authors:  Richmond N O Aryeetey; Grace S Marquis; Lucy Brakohiapa; Leo Timms; Anna Lartey
Journal:  Breastfeed Med       Date:  2009-09       Impact factor: 1.817

8.  Increased Epstein-Barr virus in breast milk occurs with subclinical mastitis and HIV shedding.

Authors:  Armen Sanosyan; David G Rutagwera; Jean-Pierre Molès; Karine Bollore; Marianne Peries; Chipepo Kankasa; Mwiya Mwiya; Thorkild Tylleskär; Nicolas Nagot; Philippe Van De Perre; Edouard Tuaillon
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

9.  Baicalin promotes the bacteriostatic activity of lysozyme on S. aureus in mammary glands and neutrophilic granulocytes in mice.

Authors:  Xuejiao Gao; Mengyao Guo; Zecai Zhang; Peng Shen; Zhengtao Yang; Naisheng Zhang
Journal:  Oncotarget       Date:  2017-03-21

10.  The immune response to sub-clinical mastitis is impaired in HIV-infected women.

Authors:  Roxane Schaub; Stéphanie Badiou; Johannes Viljoen; Pierre Dujols; Karine Bolloré; Philippe Van de Perre; Marie-Louise Newell; Ruth Bland; Nicolas Nagot; Edouard Tuaillon
Journal:  J Transl Med       Date:  2018-10-25       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.